´óÁ¬Ò½¿Æ´óѧÖ×ÁöÖÐÐÄÍôÑó¿ÎÌâ×éÕÐÊÕ2023ÄêÉúÎﻯѧºÍϸ°ûÉúÎïѧרҵµ÷¼Á˶ʿÑо¿Éú£¬Æä±¾¿ÆӦΪÉúÎﻯѧ¡¢·Ö×ÓÉúÎïѧ¡¢Ï¸°ûÉúÎïѧ¡¢ÉúÎï¼¼Êõ¼°Ò½Ñ§¡¢Ò©Ñ§µÈÏà¹ØרҵµÄ¿¼ÉúÇÒ¿¼ÑÐרҵ´úÂëÇ°Á½Î»Îª07¡£»ìѧλÕßÎðÈÅ£¡
»¶Ó¹ã´ó¿¼ÉúÓ»Ô¾µ÷¼Áµ½ÍôÑó½ÌÊÚ¿ÎÌâ×é¹¥¶Á˶ʿÑо¿Éú£¡
ÁªÏµÈËÕÅÀÏʦEmail£ºwanglab2018@sina.com
(ÂÛ̳Äڻظ´ÎÞЧ£¬ÇëÖ±½Ó·¢¼òÀúµ½ÓÊÏ䣡£©
Ò»¡¢Ñ§Ôº½éÉÜ£º
´óÁ¬Ò½¿Æ´óѧÖ×Áö¸Éϸ°ûÑо¿ÔºÊÇѧУнü´ÓÅ·ÃÀÖªÃû¸ßУ£¨Èç¹þ·ð´óѧ¡¢Ô¼º²»ôÆÕ½ð˹¡¢M.D. Anderson °©Ö¢ÖÐÐĵȣ©Òý½øµÄ¸ß¶ËÍŶӴ´½¨µÄÑо¿ÔºËù£¬ÓÚ2011Äê9ÔÂÕýʽ³ÉÁ¢¡£Ö×Áö¸Éϸ°ûÑо¿ÔºÏÖÓÐ˼ά»îÔ¾µÄ¸ßˮƽ´´ÐÂÍŶӣ¬²¢³É¹¦ÈëÑ¡2013Äê¶È¶«±±µØÇøΨһҽѧÀà½ÌÓý²¿¡°´´ÐÂÍŶӷ¢Õ¹¼Æ»®¡±¡£ÏÖÓв©Ê¿Ñо¿Éúµ¼Ê¦13ÈË£¬Ë¶Ê¿Ñо¿Éúµ¼Ê¦26ÈË£¬ÆäÖÐÓпƼ¼²¿ÖØ´ó¿ÆѧÑо¿ÏîÄ¿(973)Ê×ϯ¿Æѧ¼Ò£¬¹ú¼Ò½Ü³öÇàÄê¿Æѧ»ù½ðÏîÄ¿»ñµÃÕߣ¬ÐÂÊÀ¼Í¡°°ÙǧÍòÈ˲Ź¤³Ì¡±¹ú¼Ò¼¶ÈËÑ¡,ÎÀÉú²¿¡°ÓÐÍ»³ö¹±Ï×ÖÐÇàÄêר¼Ò¡± ¼°ÖпÆÔº¡°°ÙÈ˼ƻ®¡±ÈëÑ¡Õß¡£´´ÐÂÍŶӳÉÔ±ÏȺó»ñÅú¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÏîÄ¿58ÏÀۼƻñ×ÊÖú¿ÆÑо·Ñ×ܽð¶î´ï8362ÓàÍòÔª£¬²¢ÊµÏÖÁËÔÚ¡°½ÜÇࡱ¡°ÖصãÏîÄ¿¡±¡¢¡°ÓÅÇࡱ¡¢¸Û°Ą̈ºÏ×÷ÏîÄ¿µÄÀúÊ·Í»ÆÆ¡£ÏȺ󷢱íSCIÂÛÎÄ172ƪ£¬ÆäÖÐÓ°ÏìÒò×Ó¡Ý5µÄ87ƪ£¬¡Ý10µÄ13ƪ£¬¡Ý20µÄ1ƪ£¬¡Ý30µÄ1ƪ¡£ÏȺó¾Ù°ìÁËÁù½ìÖйú¡¤°ô颵º¹ú¼ÊÖ×ÁöÇ°ÑØÂÛ̳£¬²¢ÒÀÍÐÖйú¡¤°ô颵º¹ú¼ÊÖ×ÁöÇ°ÑØÂÛ̳×éÖ¯½¨Á¢°ô颵ºÖ×ÁöѧÉç¡£
¶þ¡¢µ¼Ê¦½éÉÜ£º
ÍôÑó½ÌÊÚÏÖΪ´óÁ¬Ò½¿Æ´óѧÖ×Áö¸Éϸ°ûÑо¿Ôº²©Ê¿Éúµ¼Ê¦£¬¹ú¼Ò½Ü³öÇàÄê»ù½ð»ñµÃÕߣ¬¹ú¼ÒÓÅÐãÇàÄê»ù½ð»ñµÃÕߣ¬ÈëÑ¡¹ú¼ÒÌØƸר¼Ò£¨ÇàÄ꣩£¬ÁÉÄþÊ¡¡°ÅʵÇѧÕß¡±£¬ÁÉÄþÊ¡¡°ÐËÁÉÓ¢²Å¼Æ»®¡±¿Æ¼¼´´ÐÂÁì¾üÈ˲ţ¨ÁÉÄþÊ¡ÌØƸ½ÌÊÚ£©¡£2007Äê±ÏÒµÓÚÖйúкÍÒ½¿Æ´óѧÖ×ÁöÑо¿Ëù·Ö×ÓÖ×Áöѧ¹ú¼ÒÖصãʵÑéÊÒ£¬»ñµÃϸ°ûÉúÎïѧ²©Ê¿Ñ§Î»£¬Í¬Ä기ÃÀ¹ú±±¿¨ÂÞÀ´ÄÉ´óѧҩÀíϵºÍLinebergerÖ×ÁöÖÐÐĽøÐв©Ê¿ºóÑо¿¡£ÔÚ´ËÆڼ䣬Ö÷ÒªÔËÓÃϸ°ûÉúÎïѧ¡¢·Ö×ÓÉúÎïѧºÍϵͳÉúÎïѧµÄ·½·¨´ÓÊÂRNAÑ¡ÔñÐÔ¼ô½ÓÓëÖ×ÁöµÄ·Ö×Ó»úÖƼ°Ó¦ÓÃÑо¿¡£½üÄêÀ´ÔÚRNAÑ¡ÔñÐÔ¼ô½ÓÓëÖ×ÁöÁìÓòµÄÑо¿ÒѾ´ïµ½¹ú¼Ê¶¥¼¶Ë®Æ½£¬ÖÁ½ñÔÚ¹ú¼ÊѧÊõ¿¯Îï·¢±íÑо¿ÂÛÎÄ40Óàƪ£¨ÀۼƽüÎåÄêÓ°ÏìÒò×Ó>450£¬ËûÒý3300Óà´Î£©£¬°üÀ¨×÷ΪͨѶºÍµÚÒ»×÷ÕßÔÚNature Methods¡¢Nature Structural & Molecular Biology¡¢Cancer Cell¡¢Nature Communications¡¢Journal of Clinical Investigation¡¢Signal Transduction and Targeted Therapy¡¢Cell Death and DifferentiationµÈ£¬ÆäÖз¢±íÔÚCancer Cell¡¢Nature Communications¡¢Journal of Clinical Investigation¡¢Cell Death and Differentiation ¡¢EBioMedicine¡¢Cell Death & Disease¡¢RNAµÈ¹ú¼ÊѧÊõ¿¯ÎïÉϵÄÂÛÎÄÈ«²¿ÔÚ¹úÄÚÍê³É¡£
Ä¿Ç°¿ÎÌâ×é°üº¬Á½Ãû½ÌÊÚ¡¢Á½Ãû¸±½ÌÊÚºÍÒ»Ãû¸ß¼¶ÊµÑéʦ¡£
´ú±íÐÔÎÄÕ£º
1. Zhang W, Sun Y, Bai L, Zhi L, Yang Y, Zhao Q , Zhang J, Zhao J, Zhang S, Yin Y, Peng C, Li X, Liu Q, Liu H, Wang Y. RBMS1 regulates lung cancer ferroptosis through translational control of SLC7A11. J Clin Invest. 2021 Nov 15;131(22):e152067. doi: 10.1172/JCI152067.£¨IF=14.808£©
2. Sisi Li#, Yang fan Qi#, Jia chuan Yu#, Yu chao Hao#, Bin He# ,Fei Peng, Zhijie Hou, Chun li Wang, Fei meng Zheng, Ling zhi Xu, Qing ping Wen, Bi lian Jin*,Yang Wang*,Quentin Liu*.Nuclear Aurora kinase A switches m6A reader YTHDC1 to enhance an oncogenic RNA splicing of tumor suppressor RBM4.Signal Transduction and Targeted Therapy. 2022 Apr 1;7(1):97. doi: 10.1038/s41392-022-00905-3.
3. Jin rui Zhang#, Ge Zhang#, Wenjing Zhang#, Lu Bai#, Luning Wang, Tiantian Li, , Yu Sun, Lili Zhi, Yang fan Qi, Jin yao Zhao, Quentin Liu, Han Liu, Yang Wang*. Loss of RBMS1 promotes anti-tumor immunity through enabling PD-L1 checkpoint blockade in triple-negative breast cancer.Cell Death and Differentiation. 2022£¬doi: 10.1038/s41418-022-01012-0
4. Lv Y, Zhang W, Zhao J, Sheng J, Wang T, Dominguez D, Liu H, Liu Q, Meng S, Li X, Wang Y. SRSF1 inhibits autophagy through regulating Bcl-x splicing and interacting with PIK3C3 in lung cancer. Signal Transduct Target Ther. 2021 Mar 5;6(1):108. doi: 10.1038/s41392-021-00495-6. (IF=18.187)
5. Qi Y, Han W, Chen D, Zhao J, Bai L, Huang F, Dai Z, Li G, Chen C, Zhang W, Zhang J, Jin B, Wang Y. Engineering circular RNA regulators to specifically promote circular RNA production. Theranostics. 2021 May 24;11(15):7322-7336. doi: 10.7150/thno.56990. (IF=11.556)
6. Yang Wang*£¬Dan Chen£¬Haili Qian£¬Yihsuan Tsai£¬Shujuan Shao£¬Quentin Liu£¬Daniel Dominguez£¬Zefeng Wang(*)£¬The Splicing Factor RBM4 Controls Apoptosis, Proliferation, and Migration to Suppress Tumor Progression.£¬Cancer Cell£¬2014£¬26£¨3£©£º374-389.(SCI, IF=31.743) ͨѶ×÷Õß
ÏêϸÐÅÏ¢¿ÉµÇ½ÈçÏÂÍøÕ¾²é¿´£º
http://icsc.dmu.edu.cn/info/1064/1441.htm
Èý¡¢µ÷¼ÁÌõ¼þ£º
1¡¢È«ÈÕÖÆÓ¦½ì»òÍù½ì±¾¿Æ±ÏÒµÉú£»
2¡¢·ûºÏÎÒУ2023Äê¹¥¶Á˶ʿѧλÑо¿ÉúÕÐÉú¼òÕÂÒªÇ󣬳õÊԳɼ¨´ïµ½È«¹úÒ»ÀàµØÇø˶ʿÑо¿Éú³õÊÔ·ÖÊýÏߣ»
3¡¢Ó¢Óïˮƽ£ºCET-6³É¼¨¸ßÓÚ425·ÖÕßÓÅÏÈ£»
4¡¢ÓÅÏÈ¿¼ÂDZ¾¿Æ±ÏҵԺУΪ¡°985¡±»ò¡°211¡±µÄ¿¼Éú£»ÓÅÏÈ¿¼ÂÇÓÐʵÑéÊÒ¹¤×÷¾ÀúÕß
ËÄ¡¢ÕÐÉúרҵ¼°Ãû¶î£º
¹²ÕÐÊÕ4Ãû˶ʿÑо¿Éú£¬Ï¸°ûÉúÎïѧ ¡£
Îå¡¢ÁªÏµ·½Ê½£º
ÓÐÒâµ½ÎÒ¿ÎÌâ×é¹¥¶Á˶ʿÑо¿ÉúµÄ¿¼Éú£¬½«¸öÈË×ÔÊöºÍ¼òÀú£¨°üÀ¨Ñ§Ï°½ÌÓý¾Àú¡¢¹¤×÷¾Àú¡¢ÒÑ·¢±íÎÄÕ¡¢±¾¿Æ³É¼¨¡¢Ó¢ÓïËÄÁù¼¶³É¼¨µÈ£©·¢ËÍÖÁwanglab2018@sina.com
Áù¡¢ÀøÖ¾ÖúѧÕþ²ß£º
1¡¢ÎÒÔºÑо¿ÉúÔÚ¶ÁÆڼ䣬³ýÏíÊܹú¼ÒºÍѧУµÄ¸÷Àà½òÌùÍ⣬¿ÎÌâ×éÿÔÂÌṩÉú»î²¹Öú£»
2¡¢ÎÒԺΪÓÅÐãÑо¿ÉúÌṩ˶²©Á¬¶ÁµÄ»ú»á£»
3¡¢ÎÒÔº½«ÔñÓÅÍƼöÑо¿Éú³ö¹úÉîÔìµÄ»ú»á¡£
»¶Ó¹ã´ó¿¼ÉúÓ»Ô¾µ÷¼Áµ½ÍôÑó½ÌÊÚ¿ÎÌâ×é¹¥¶Á˶ʿÑо¿Éú£¡ |